跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMGEVITA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMGEVITA
Authorized
STANDARD
AMGEVITA
Amgen Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
48ef70c4b25e7a8a
Company
Amgen Canada Inc
Type
Standard
Approval Details
Approval Id
48ef70c4b25e7a8a
Drug Approval Canada Name
AMGEVITA
Product Name
AMGEVITA
Status
Marketed
Status Date
2021-02-19
Original Market Date
2021-02-19
Din
02459302
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
90:24.16.92
Atc Original
L04AB04 ADALIMUMAB
Atc Name
l 04 ab 04
Aig Number
0150364003
Company Name
Amgen Canada Inc
Company Address
300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4
Active Ingredients
ADALIMUMAB
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
48ef70c4b25e7a8a
Type
Standard
Back to Health Canada Approvals